Heading For 2023: Memscap Announces the Sale of Its North Carolina Manufacturing Plant to Science Corporation & the Conclusion of a Strategic Supply Agreement for Optical Communications Products
2022年12月8日 - 2:30AM
ビジネスワイヤ(英語)
On-time Completion of the FABLITE Program according to
Initial Company Plan
MEMSCAP New Organization improving agility and profitability
profile
Regulatory News:
MEMSCAP (NYSE Euronext: MEMS), the leading provider of
innovative solutions based on MEMS (micro-electro-mechanical
systems) technology, today announced it has fully executed its
FABLITE Program through the sale of its North Carolina
Manufacturing Plant (USA) and the conclusion of a strategic supply
agreement for its optical communications products.
North Carolina Manufacturing Plant Sale Transaction
MEMSCAP entered into a definitive Asset Purchase Agreement with
Science Corporation, a California-based Company which develops
advanced technologies with the goal to blur the lines between
medical devices and consumer electronics, covering the sale and
transfer of certain assets of its US subsidiary (MEMSCAP Inc.),
including:
- The entire North Carolina teams. - The
North Carolina plant lease as well as all plant’s tools and
equipment and associated technology. - The foundry business
customers.
The purchase price to acquire the above assets totals 3.0
million US dollars.
The Asset Purchase Agreement excludes the Variable Optical
Attenuator (VOA) Products, Intellectual Property and Business
(MEMSCAP Optical Communications Business), which remain the
ownership of MEMSCAP.
Strategic Supply Agreement of VOA Products
Concurrent with the Sale Transaction closing, MEMSCAP and
Science Corporation entered into a strategic supply agreement for
the manufacturing and supply of products for the MEMSCAP VOA
business. Such Agreement includes a minimum of 3 years supply of
chips and wafers.
Analysis and perspectives
Following this transaction and the on-schedule completion of the
FABLITE Program, MEMSCAP business becomes focused around:
- the Avionics and Medical businesses
operated by MEMSCAP Norwegian facilities, and - the fabless VOA
Product line servicing MEMSCAP Optical Communications business.
This new organization is expecting to deliver significant
improvement to MEMSCAP agility and profitability.
“We are delighted to enter this transaction with Science
Corporation, assuring to our teams in North Carolina a solid new
home and for MEMSCAP the continuity of servicing the Optical
Communications business with the same standards.”, said Jean Michel
Karam, Chairman & CEO of MEMSCAP. “We are very pleased for
having conducted the FABLITE Program from the idea to an
on-schedule implementation. Today, we are excited to enter 2023
with such agile organization we planned three years ago.”
Q4 2022 earnings: January 25, 2023.
About MEMSCAP
MEMSCAP is the leading provider of innovative
micro-electro-mechanical systems (MEMS)-based solutions.
MEMSCAP’s products and solutions include components, component
designs (IP), manufacturing and related services.
MEMSCAP is listed on Euronext Paris ™ - Segment C - ISIN:
FR0010298620 - MEMS.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221207005667/en/
Yann Cousinet Chief Financial Officer Ph.: +33 (0) 4 76 92 85 00
yann.cousinet@memscap.com
For more information, visit our website at:
www.memscap.com
Memscap (EU:MEMS)
過去 株価チャート
から 3 2024 まで 4 2024
Memscap (EU:MEMS)
過去 株価チャート
から 4 2023 まで 4 2024